复宏汉霖(02696):注射用HLX43单药或联合PIMURUTAMAB HLX07于日本获许可开展用于晚期鳞状非小细胞肺癌治疗的国际多中心2/3期临床试验
Last Update:
4 5 月, 2026
Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.